Evidence map›Paper›PMID 41877189›Full record

ArticleCell communication and signaling : CCS2026

NSP1 of Alongshan virus antagonizes type I interferon responses by promoting STUB1-mediated degradation of RIG-I.

Fengchao Xu, Hongxiao Song, Rongxing Ming, Yujia Zhu, Mian Huang, Jing Xu, Le Wang, Xiaolu Li, Fan Yang, Huifan Ji and 1 more

Abstract read
In one paragraph

Article in Cell communication and signaling : CCS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Fengchao XuDepartment of Hepatology, Center of Infectious Diseases and Pathogen Biology, Institute of Translational Medicine, The First Hospital of Jilin University, Changchun, Jilin, 130021, China.
Hongxiao SongDepartment of Hepatology, Center of Infectious Diseases and Pathogen Biology, Institute of Translational Medicine, The First Hospital of Jilin University, Changchun, Jilin, 130021, China.
Rongxing MingDepartment of Respiratory Medicine, The First People's Hospital of Nankang District, Ganzhou, Jiangxi, 341400, China.
Yujia ZhuDepartment of Hepatology, Center of Infectious Diseases and Pathogen Biology, Institute of Translational Medicine, The First Hospital of Jilin University, Changchun, Jilin, 130021, China.
Mian HuangDepartment of Hepatology, Center of Infectious Diseases and Pathogen Biology, Institute of Translational Medicine, The First Hospital of Jilin University, Changchun, Jilin, 130021, China.
Jing XuHealth Examination Center, The First Hospital of Jilin University, Changchun, Jilin, 130021, China.
Le WangDepartment of Hepatology, Center of Infectious Diseases and Pathogen Biology, Institute of Translational Medicine, The First Hospital of Jilin University, Changchun, Jilin, 130021, China.
Xiaolu LiDepartment of Pediatrics, the First Hospital, Jilin University, Changchun, Jilin, 130021, China.
Fan YangDepartment of Anesthesiology, the First Hospital, Jilin University, Changchun, Jilin, 130021, China.
Huifan JiDepartment of Hepatology, Center of Infectious Diseases and Pathogen Biology, Institute of Translational Medicine, The First Hospital of Jilin University, Changchun, Jilin, 130021, China.
Guangyun TanDepartment of Hepatology, Center of Infectious Diseases and Pathogen Biology, Institute of Translational Medicine, The First Hospital of Jilin University, Changchun, Jilin, 130021, China. tgy0425@jlu.edu.cn.

Funding

National Natural Science Foundation of China 82371765
6 · The paper itself

Abstract

Emerging tick-borne viruses have become a significant public health concern due to their association with severe human illnesses. Among these, Alongshan virus (ALSV), a segmented RNA virus first identified in northeastern China, has been linked to febrile illness, presenting with fever, headache, myalgia, and, in severe cases, multi-organ failure. Despite its clinical relevance, the mechanisms by which ALSV evades host immune defenses remain poorly understood. Here, we identify NSP1, a nonstructural protein of ALSV, as a potent inhibitor of type I interferon (IFN-I) production, specifically targeting the RIG-I signaling pathway. Mechanistically, NSP1 binds to RIG-I, preventing its interaction with MAVS and facilitating RIG-I’s STUB1-mediated K48-linked polyubiquitination and subsequent proteasomal degradation. By disrupting the RIG-I/MAVS complex and promoting the targeted degradation of RIG-I, NSP1 effectively suppresses the IFN-I response, a critical component of the host antiviral defense. Our study provides a dual mechanism through which NSP1 impairs immune detection, highlighting its role in immune evasion and viral persistence. These findings not only advance our understanding of ALSV pathogenesis but also offer a potential therapeutic target for antiviral interventions, shedding light on broader strategies employed by viruses to subvert host immune responses.

Indexed as

DEAD Box Protein 58Interferon Type IProteolysisUbiquitin-Protein LigasesViral Nonstructural ProteinsAdaptor Proteins, Signal TransducingAnimalsHEK293 CellsHumansProtein BindingReceptors, ImmunologicSignal TransductionUbiquitinationAdaptor Proteins, Signal TransducingDEAD Box Protein 58Interferon Type IReceptors, ImmunologicRIGI protein, humanUbiquitin-Protein LigasesViral Nonstructural ProteinsALSVInterferonMAVSNSP1RIG-I

Identifiers

PMID41877189
PMCPMC13134197

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.